Denosumab 60mg InjectionInjection
Musculoskeletal & Orthopedic

Denosumab 60mg Injection

Denosumab

RANKL monoclonal antibody inhibiting osteoclast formation for osteoporosis treatment with twice-yearly subcutaneous dosing. Manufactured by Biocon and Cipla for orthopedic/rheumatology export.

Strengths

60mg / 120mg

Packing

1 prefilled syringe/box

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Denosumab 60mg/ml solution for subcutaneous injection
Dosage Form
Injection
Available Strengths
60mg / 120mg
Packing
1 prefilled syringe/box
Route of Administration
Subcutaneous injection
Dosage
Osteoporosis: 60mg SC every 6 months; Bone metastases (120mg): every 4 weeks
Indications
Postmenopausal osteoporosis, male osteoporosis, glucocorticoid-induced osteoporosis, bone metastases prevention of skeletal events
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 2-8°C, do not freeze, protect from light
Shelf Life
36 months
Side Effects
Back pain, extremity pain, musculoskeletal pain, hypocalcemia, cystitis, upper respiratory infection
Precautions
Ensure adequate calcium and vitamin D supplementation; osteonecrosis of jaw risk; atypical femur fractures with prolonged use; rebound vertebral fractures on discontinuation — transition to bisphosphonate

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Colchicine 0.5mgTablet

Colchicine 0.5mg

Colchicine

Plant-derived anti-inflammatory alkaloid that inhibits microtubule polymerisation and neutrophil degranulation, providing rapid and effective relief of acute gouty arthritis within hours of administration. Beyond gout, it has proven efficacy in reducing pericarditis recurrence and is the treatment of choice for familial Mediterranean fever, with a narrow therapeutic index requiring careful dose titration.

0.5mg / 0.6mg
Calcium + CalcitriolTablet

Calcium + Calcitriol

Calcium Carbonate + Calcitriol

Fixed-dose combination of elemental calcium with calcitriol, the hormonally active form of vitamin D3 that bypasses both hepatic and renal hydroxylation steps, making it the preparation of choice in chronic kidney disease mineral bone disorder and hypoparathyroidism. Direct stimulation of intestinal calcium absorption and bone mineralisation is achieved even in patients with severely impaired renal 1-alpha-hydroxylase activity.

500mg Ca + 0.25mcg Calcitriol
Alendronate 70mgTablet

Alendronate 70mg

Alendronate Sodium

Nitrogen-containing bisphosphonate that potently inhibits osteoclast-mediated bone resorption, with landmark clinical trials demonstrating significant reductions in vertebral and hip fracture risk in postmenopausal osteoporosis. The 70mg once-weekly formulation substantially improves patient adherence compared to daily dosing while delivering equivalent anti-resorptive efficacy.

10mg daily / 70mg weekly

Need bulk pricing for Denosumab 60mg Injection?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote